Literature DB >> 3657666

Indirect haemagglutination test for melioidosis.

L R Ashdown.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3657666     DOI： 10.5694/j.1326-5377.1987.tb133542.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  9 in total

Review 1.  Laboratory diagnosis of melioidosis: past, present and future.

Authors:  Susanna K P Lau; Siddharth Sridhar; Chi-Chun Ho; Wang-Ngai Chow; Kim-Chung Lee; Ching-Wan Lam; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

2.  Evidence of Burkholderia pseudomallei-specific immunity in patient sera persistently nonreactive by the indirect hemagglutination assay.

Authors:  Patrick N A Harris; Natasha L Williams; Jodie L Morris; Natkunam Ketheesan; Robert E Norton
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

3.  Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity.

Authors:  Jodie Morris; Natasha Williams; Catherine Rush; Brenda Govan; Kunwarjit Sangla; Robert Norton; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

Review 4.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 5.  Melioidosis: the tip of the iceberg?

Authors:  D A Dance
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

6.  Evaluation of immunoglobulin M (IgM) and IgG rapid cassette test kits for diagnosis of melioidosis in an area of endemicity.

Authors:  Vanaporn Wuthiekanun; Premjit Amornchai; Wirongrong Chierakul; Allen C Cheng; Nicholas J White; Sharon J Peacock; Nicholas P J Day
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

7.  Diagnosis of melioidosis by means of an ELISA detecting antibodies toPseudomonas pseudomallei exotoxin. Preliminary assay evaluation.

Authors:  C J Smith; M Jones; D A Dance; W Chaowagul; N J White
Journal:  World J Microbiol Biotechnol       Date:  1991-01       Impact factor: 3.312

8.  Clinical features that affect indirect-hemagglutination-assay responses to Burkholderia pseudomallei.

Authors:  Patrick N A Harris; Natkunam Ketheesan; Leigh Owens; Robert E Norton
Journal:  Clin Vaccine Immunol       Date:  2009-04-29

9.  Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis.

Authors:  M R O'Carroll; T J Kidd; C Coulter; H V Smith; B R Rose; C Harbour; S C Bell
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.